Clinical Trials · NCT01086982
Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®
- Phase
- Phase 1
- Recruitment status
- Suspended
- Sponsor
- Azidus Brasil
- Enrollment
- 16
- Start date
- Mar 2010
- Locations
- 1 site, Brazil
- Primary endpoint
- Quantification of serum levels of GH and IGF-I.